Essential Medicines List for Management of Patients Admitted to Intensive Care Units with Suspected or Confirmed COVID-19 Diagnosis, 24 March 2020
dc.date.accessioned | 2020 | |
dc.date.available | 2020 | |
dc.date.issued | 2020 | |
dc.identifier.govdoc | PAHO/HSS/MT/COVID-19/20-0019 | |
dc.identifier.uri | https://iris.paho.org/handle/10665.2/52191 | |
dc.description.abstract | This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essential Medicines 2019; based on clinical presentations and symptoms identified and prioritized in World Health Organization (WHO) and Surviving Sepsis Campaign (SSC) guidelines and the evidence presented in these guidelines. | en_US |
dc.language.iso | en | en_US |
dc.publisher | PAHO | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 IGO | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/igo/ | * |
dc.subject | Health Services | en_US |
dc.subject | Health Services | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | Access to Essential Medicines and Health Technologies | en_US |
dc.title | Essential Medicines List for Management of Patients Admitted to Intensive Care Units with Suspected or Confirmed COVID-19 Diagnosis, 24 March 2020 | en_US |
dc.type | Procedures, manuals, guidelines | en_US |
dc.rights.holder | Pan American Health Organization | en_US |
dc.contributor.corporatename | Pan American Health Organization | en_US |
paho.isfeatured | 0 | en_US |
paho.publisher.country | United States | en_US |
paho.publisher.city | Washington, D.C. | en_US |
paho.source.centercode | US1.1 | en_US |
paho.relation.languageVersion | 10665.2/52192 | |
paho.contributor.department | Health Systems and Services (HSS) | en_US |
paho.iswhotranslation | No | en_US |